Madam Speaker, to be frank, I have a nephew who has a rare condition, one of five in Canada. Rare diseases and rare disease drugs are so important too, especially for my family.
There is a special process for Canadians to access rare disease drugs. There is an application process they can go through. On Trikafta, I believe over 200 Canadians, if I am not mistaken, have applied for that drug and have received it. We are investing $500 million into a rare disease drug strategy. We will be there for Canadians, especially our most vulnerable Canadians who are inflicted with a rare disease.